Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045938
Filing Date
2024-11-14
Accepted
2024-11-14 16:30:41
Documents
40
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 375070
2 ex31-1.htm EX-31.1 17579
3 ex32-1.htm EX-32.1 6786
  Complete submission text file 0001493152-24-045938.txt   2046854

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20240930.xsd EX-101.SCH 15164
5 XBRL CALCULATION FILE glsi-20240930_cal.xml EX-101.CAL 22104
6 XBRL DEFINITION FILE glsi-20240930_def.xml EX-101.DEF 66815
7 XBRL LABEL FILE glsi-20240930_lab.xml EX-101.LAB 145219
8 XBRL PRESENTATION FILE glsi-20240930_pre.xml EX-101.PRE 121565
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 189419
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 241463134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)